Clinical management of motility disorders in children

Seminars in Pediatric Surgery

Volumn 18, Issue 4, 2009, Pages 224-238

  Gariepy, Cheryl E ^a,b   Mousa, Hayat ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic intestinal pseudoobstruction; Constipation; Fecal incontinence; Fundoplication; Gastroparesis; Imperforate anus

Indexed keywords

AMITRIPTYLINE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYPROHEPTADINE; DOMPERIDONE; ERYTHROMYCIN; LAXATIVE; LOPERAMIDE; LUBIPROSTONE; MACROGOL 3350; METOCLOPRAMIDE; NIFEDIPINE; NITRITE; ONDANSETRON; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PROBIOTIC AGENT; PROKINETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANUS ATRESIA; ARTICLE; BALLOON DILATATION; BEHAVIOR THERAPY; CECOSTOMY; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; COLON RESECTION; CONSTIPATION; DIET THERAPY; DRUG MECHANISM; DYSPHAGIA; ELECTROSTIMULATION THERAPY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; ESOPHAGUS MYOTOMY; FECES INCONTINENCE; GAS BLOAT SYNDROME; GASTRIC HYPERSENSITIVITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY DISORDER; GASTROSCHISIS; GASTROSTOMY; GRAFT REJECTION; HIRSCHSPRUNG DISEASE; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE ATRESIA; INTESTINE INFECTION; INTESTINE OBSTRUCTION; INTESTINE PSEUDOOBSTRUCTION; INTESTINE TRANSPLANTATION; LOW DRUG DOSE; MEDICAL LITERATURE; NAUSEA; NONHUMAN; PARENTERAL NUTRITION; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STOMACH FUNDOPLICATION; STOMACH PARESIS; TARDIVE DYSKINESIA; UNITED STATES;

CHILD; CHILD, PRESCHOOL; CONSTIPATION; DIGESTIVE SYSTEM ABNORMALITIES; DUMPING SYNDROME; ESOPHAGEAL MOTILITY DISORDERS; FUNDOPLICATION; GASTROINTESTINAL MOTILITY; GASTROPARESIS; GASTROSCHISIS; HUMANS; INFANT; INFANT, NEWBORN; INTESTINAL PSEUDO-OBSTRUCTION;

EID: 70349275527     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2009.07.004     Document Type: Article

References (100)

1. Brooks B.P., Kleta R., Stuart C., et al. Genotypic heterogeneity and clinical phenotype in triple A syndrome: A review of the NIH experience 2000-2005. Clin Genet 68 (2005) 215-221
2. Wallace R.A. Clinical audit of gastrointestinal conditions occurring among adults with Down's syndrome attending a specialist clinic. J Intellect Dev Disabil 32 (2007) 45-50
3. Pohl D., and Tutuian R. Achalasia: An overview of diagnosis and treatment. J Gastrointestin Liver Dis 16 (2007) 297-303
4. Gockel I., Bohl J.R., Doostkam S., et al. Spectrum of histopathologic findings in patients with achalasia reflects different etiologies. J Gastroenterol Hepatol 21 (2006) 727-733
5. Triadafilopoulos G., Aaronson M., Sackel S., et al. Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil, and placebo. Dig Dis Sci 36 (1991) 260-267
6. Traube M., Dubovik S., Lange R.C., et al. The role of nifedipine therapy in achalasia: Results of a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 84 (1989) 1259-1262
7. Annese V., Bassotti G., Coccia G., et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 46 (2000) 597-600
8. Lamb P.J., and Griffin S.M. Achalasia of the cardia: Dilatation or division?. The case for balloon dilatation. Ann R Coll Surg Engl 88 (2006) 9-11
9. Wang L., Li Y.M., and Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci (2008) Epub ahead of print
10. Ortiz A., de Haro L.F., Parrilla P., et al. Very long-term objective evaluation of Heller myotomy plus posterior partial fundoplication in patients with achalasia of the cardia. Ann Surg 247 (2008) 258-264
11. Pandolfo N., Bortolotti M., Spigno L., et al. Manometric assessment of Heller-Dor operation for esophageal achalasia. Hepatogastroenterology 43 (1996) 160-166
12. Pensabene L., and Nurko S. Approach to the child who has persistent dysphagia after surgical treatment for esophageal achalasia. J Pediatr Gastroenterol Nutr 47 (2008) 92-97
13. Kawahara H., Nakajima K., Yagi M., et al. Mechanisms responsible for recurrent gastroesophageal reflux in neurologically impaired children who underwent laparoscopic Nissen's fundoplication. Surg Endosc 16 (2002) 767-771
14. Omari T.I., Barnett C.P., Benninga M.A., et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut 51 (2002) 475-479
15. Ewer A.K., Durbin G.M., Morgan M.E., et al. Gastric emptying in preterm infants. Arch Dis Child Fetal Neonatal Ed 71 (1994) F24-F27
16. Srivastava R., Downey E.C., O'Gorman M., et al. Impact of fundoplication versus gastrojejunal feeding tubes on mortality and in preventing aspiration pneumonia in young children with neurologic impairment who have gastroesophageal reflux disease. Pediatrics 123 (2009) 338-345
17. Spechler S.J., Lee E., Ahnen D., et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial. J Am Med Assoc 285 (2001) 2331-2338
18. Strate U., Emmermann A., Fibbe C., et al. Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc 22 (2008) 21-30
19. Bhayani M.K., Smith A.D., Baroody F.M., et al. Distal esophageal foreign bodies: Is it a common occurrence post-fundoplication requiring immediate intervention?. Int J Pediatr Otorhinolaryngol 73 (2009) 377-381
20. Mousa H., Caniano D.A., Alhajj M., et al. Effect of Nissen fundoplication on gastric motor and sensory functions. J Pediatr Gastroenterol Nutr 43 (2006) 185-189
21. Vu M.K., Ringers J., Arndt J.W., et al. Prospective study of the effect of laparoscopic hemifundoplication on motor and sensory function of the proximal stomach. Br J Surg 87 (2000) 338-343
22. Wijnhoven B.P., Salet G.A., Roelofs J.M., et al. Function of the proximal stomach after Nissen fundoplication. Br J Surg 85 (1998) 267-271
23. Tack J., Coulie B., Wilmer A., et al. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 46 (2000) 468-473
24. Tack J. Functional dyspepsia: Impaired fundic accommodation. Curr Treat Options Gastroenterol 3 (2000) 287-294
25. Di Lorenzo C., Flores A., and Hyman P.E. Intestinal motility in symptomatic children with fundoplication. J Pediatr Gastroenterol Nutr 12 (1991) 169-173
26. Stanghellini V., and Malagelada J.R. Gastric manometric abnormalities in patients with dyspeptic symptoms after fundoplication. Gut 24 (1983) 790-797
27. Fung K.P., Seagram G., Pasieka J., et al. Investigation and outcome of 121 infants and children requiring Nissen fundoplication for the management of gastroesophageal reflux. Clin Invest Med 13 (1990) 237-246
28. Hillemeier A.C., Lange R., McCallum R., et al. Delayed gastric emptying in infants with gastroesophageal reflux. J Pediatr 98 (1981) 190-193
29. Bufler P., Ehringhaus C., and Koletzko S. Dumping syndrome: A common problem following Nissen fundoplication in young children. Pediatr Surg Int 17 (2001) 351-355
30. Ng D.D., Ferry Jr. R.J., Kelly A., et al. Acarbose treatment of postprandial hypoglycemia in children after Nissen fundoplication. J Pediatr 139 (2001) 877-879
31. Naftali T., Yishai R., Zangen T., et al. Post-infectious gastroparesis: Clinical and electerogastrographic aspects. J Gastroenterol Hepatol 22 (2007) 1423-1428
32. Sigurdsson L., Flores A., Putnam P.E., et al. Postviral gastroparesis: Presentation, treatment, and outcome. J Pediatr 131 (1997) 751-754
33. Forster J., Damjanov I., Lin Z., et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 9 (2005) 102-108
34. Zarate N., Mearin F., Wang X.Y., et al. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: Pathological findings and management. Gut 52 (2003) 966-970
35. Sokol H., Lavergne-Slove A., Mikol J., et al. Severe isolated myopathic gastroparesis: A case report with pathological findings. Gut 55 (2006) 1662
36. Martin S.T., Collins C.G., Fitzgibbon J., et al. Gastric motor dysfunction: Is eosinophilic mural gastritis a causative factor?. Eur J Gastroenterol Hepatol 17 (2005) 983-986
37. De Giorgio R., Barbara G., Stanghellini V., et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol 12 (2000) 613-616
38. Abell T.L., Camilleri M., Donohoe K., et al. Consensus recommendations for gastric emptying scintigraphy: A joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol 36 (2008) 44-54
39. Camilleri M., Hasler W.L., Parkman H.P., et al. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 115 (1998) 747-762
40. Rayner C.K., Su Y.C., Doran S.M., et al. The stimulation of antral motility by erythromycin is attenuated by hyperglycemia. Am J Gastroenterol 95 (2000) 2233-2241
41. Sturm A., Holtmann G., Goebell H., et al. Prokinetics in patients with gastroparesis: A systematic analysis. Digestion 60 (1999) 422-427
42. Ray W.A., Murray K.T., Meredith S., et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 351 (2004) 1089-1096
43. Grimes J.D. Parkinsonism and tardive dyskinesia associated with long-term metoclopramide therapy. N Engl J Med 305 (1981) 1417
44. Sawhney M.S., Prakash C., Lustman P.J., et al. Tricyclic antidepressants for chronic vomiting in diabetic patients. Dig Dis Sci 52 (2007) 418-424
45. Bromer M.Q., Friedenberg F., Miller L.S., et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 61 (2005) 833-839
46. Ayinala S., Batista O., Goyal A., et al. Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc 61 (2005) 455-461
47. Dalla Vecchia L.K., Grosfeld J.L., West K.W., et al. Intestinal atresia and stenosis: A 25-year experience with 277 cases. Arch Surg 133 (1998) 490-496 discussion 496-7
48. Takahashi A., Tomomasa T., Suzuki N., et al. The relationship between disturbed transit and dilated bowel, and manometric findings of dilated bowel in patients with duodenal atresia and stenosis. J Pediatr Surg 32 (1997) 1157-1160
49. Alvarez S.P., Greco M.A., and Genieser N.B. Small intestinal atresia and segmental absence of muscle coats. Hum Pathol 13 (1982) 948-951
50. Ozguner I.F., Savas C., Ozguner M., et al. Intestinal atresia with segmental musculature and neural defect. J Pediatr Surg 40 (2005) 1232-1237
51. Khen N., Jaubert F., Sauvat F., et al. Fetal intestinal obstruction induces alteration of enteric nervous system development in human intestinal atresia. Pediatr Res 56 (2004) 975-980
52. Caron F., Ducrotte P., Lerebours E., et al. Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings. Antimicrob Agents Chemother 35 (1991) 1085-1088
53. Jadcherla S.R., Gupta A., Stoner E., et al. Neuromotor markers of esophageal motility in feeding intolerant infants with gastroschisis. J Pediatr Gastroenterol Nutr 47 (2008) 158-164
54. Lund C.H., Bauer K., and Berrios M. Gastroschisis: Incidence, complications, and clinical management in the neonatal intensive care unit. J Perinat Neonatal Nurs 21 (2007) 63-68
55. Puri A., and Bajpai M. Gastroschisis and omphalocele. Indian J Pediatr 66 (1999) 773-789
56. Curry J.I., Lander A.D., and Stringer M.D. A multicenter, randomized, double-blind, placebo-controlled trial of the prokinetic agent erythromycin in the postoperative recovery of infants with gastroschisis. J Pediatr Surg 39 (2004) 565-569
57. Uchida H., Yamamoto H., Kisaki Y., et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 39 (2004) 634-636
58. Vargas J.H., Sachs P., and Ament M.E. Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 7 (1988) 323-332
59. Mousa H., Bueno J., Griffiths J., et al. Intestinal motility after small bowel transplantation. Transplant Proc 30 (1998) 2535-2536
60. Miele E., Tozzi A., Staiano A., et al. Persistence of abnormal gastrointestinal motility after operation for Hirschsprung's disease. Am J Gastroenterol 95 (2000) 1226-1230
61. Goulet O., Jobert-Giraud A., Michel J.L., et al. Chronic intestinal pseudo-obstruction syndrome in pediatric patients. Eur J Pediatr Surg 9 (1999) 83-89
62. Connor F.L., and Di Lorenzo C. Chronic intestinal pseudo-obstruction: Assessment and management. Gastroenterology 130 suppl 1 (2006) S29-S36
63. Lee J., Murr M., Foley M.K., et al. Role of the vagal branches to the proximal stomach in mediating gastric distention-induced disruption of canine interdigestive upper gut motility. J Surg Res 58 (1995) 576-582
64. Shibata C., Naito H., Funayama Y., et al. Surgical treatment of chronic intestinal pseudo-obstruction: Report of three cases. Surg Today 33 (2003) 58-61
65. Forster J., Sarosiek I., Delcore R., et al. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 182 (2001) 676-681
66. Sugitani A., Reynolds J.C., Tsuboi M., et al. Extrinsic intestinal reinnervation after canine small bowel autotransplantation. Surgery 123 (1998) 25-35
67. Watanabe T., Hoshino K., Tanabe M., et al. Correlation of motility and neuronal integrity with a focus on the grade of intestinal allograft rejection. Am J Transplant 8 (2008) 529-536
68. David A.I., Selvaggi G., Ruiz P., et al. Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal tranplantation. Transplantation 84 (2007) 1077-1081
69. Sudan D., Vargas L., Sun Y., et al. Calprotectin: A novel noninvasive marker for intestinal allograft monitoring. Ann Surg 246 (2007) 311-315
70. Imseis E., and Gariepy C.E. Hirschsprung's disease. In: Kleinman R., goulet O., Miele-Vergani G., et al. (Eds). Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, and Management. (ed 5) (2008), B.C. Decker, Hamilton 683-691
71. Singh S.J., Croaker G.D., Manglick P., et al. Hirschsprung's disease: The Australian Paediatric Surveillance Unit's experience. Pediatr Surg Int 19 (2003) 247-250
72. Haricharan R.N., and Georgeson K.E. Hirschsprung's disease. Semin Pediatr Surg 17 (2008) 266-275
73. Levitt M.A., Martin C.A., Olesevich M., et al. Hirschsprung's disease and fecal incontinence: Diagnostic and management strategies. J Pediatr Surg 44 (2009) 271-277
74. Hamid S.A., Di Lorenzo C., Reddy S.N., et al. Bisacodyl and high-amplitude-propagating colonic contractions in children. J Pediatr Gastroenterol Nutr 27 (1998) 398-402
75. Arnbjornsson E., Breland U., Kullendorff C.M., et al. Effect of loperamide on faecal control after rectoplasty for high imperforate anus. Acta Chir Scand 152 (1986) 215-216
76. Sun W.M., Read N.W., and Verlinden M. Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scand J Gastroenterol 32 (1997) 34-38
77. Rasquin A., Di Lorenzo C., Forbes D., et al. Childhood functional gastrointestinal disorders: Child/adolescent. Gastroenterology 130 (2006) 1527-1537
78. Youssef N.N., Peters J.M., Henderson W., et al. Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr 141 (2002) 410-414
79. Pashankar D.S., Bishop W.P., and Loening-Baucke V. Long-term efficacy of polyethylene glycol 3350 for the treatment of chronic constipation in children with and without encopresis. Clin Pediatr (Phila) 42 (2003) 815-819
80. Voskuijl W., de Lorijn F., Verwijs W., et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: A double blind, randomised, controlled, multicentre trial. Gut 53 (2004) 1590-1594
81. Pashankar D.S., Loening-Baucke V., and Bishop W.P. Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children. Arch Pediatr Adolesc Med 157 (2003) 661-664
82. Michail S., Gendy E., Preud'Homme D., et al. Polyethylene glycol for constipation in children younger than eighteen months old. J Pediatr Gastroenterol Nutr 39 (2004) 197-199
83. Loening-Baucke V., Krishna R., and Pashankar D.S. Polyethylene glycol 3350 without electrolytes for the treatment of functional constipation in infants and toddlers. J Pediatr Gastroenterol Nutr 39 (2004) 536-539
84. Marteau P., Cuillerier E., Meance S., et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: A double-blind, randomized, controlled study. Aliment Pharmacol Ther 16 (2002) 587-593
85. Agrawal A., Houghton L.A., Morris J., et al. Clinical trial: The effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2008) Epub ahead of print
86. Koebnick C., Wagner I., Leitzmann P., et al. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 17 (2003) 655-659
87. Banaszkiewicz A., and Szajewska H. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: A double-blind, placebo-controlled randomized trial. J Pediatr 146 (2005) 364-369
88. Samuel B.S., Shaito A., Motoike T., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105 (2008) 16767-16772
89. Camilleri M., Bharucha A.E., Ueno R., et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 290 (2006) G942-G947
90. Borrelli O., Barbara G., Di Nardo G., et al. Neuroimmune interaction and anorectal motility in children with food allergy-related chronic constipation. Am J Gastroenterol 104 (2009) 454-463
91. Iacono G., Cavataio F., Montalto G., et al. Intolerance of cow's milk and chronic constipation in children. N Engl J Med 339 (1998) 1100-1104
92. Daher S., Tahan S., Sole D., et al. Cow's milk protein intolerance and chronic constipation in children. Pediatr Allerg Immunol 12 (2001) 339-342
93. Vanderhoof J.A., Perry D., Hanner T.L., et al. Allergic constipation: Association with infantile milk allergy. Clin Pediatr (Phila) 40 (2001) 399-402
94. Rosen R., Buonomo C., Andrade R., et al. Incidence of spinal cord lesions in patients with intractable constipation. J Pediatr 145 (2004) 409-411
95. Villarreal J., Sood M., Zangen T., et al. Colonic diversion for intractable constipation in children: Colonic manometry helps guide clinical decisions. J Pediatr Gastroenterol Nutr 33 (2001) 588-591
96. Hassett S., Snell S., Hughes-Thomas A., et al. 10-year outcome of children born with anorectal malformation, treated by posterior sagittal anorectoplasty, assessed according to the Krickenbeck classification. J Pediatr Surg 44 (2009) 399-403
97. Heikenen J.B., Werlin S.L., Di Lorenzo C., et al. Colonic motility in children with repaired imperforate anus. Dig Dis Sci 44 (1999) 1288-1292
98. Herndon C.D., Rink R.C., Cain M.P., et al. In situ Malone antegrade continence enema in 127 patients: A 6-year experience. J Urol 172 (2004) 1689-1691
99. Sierre S., Lipsich J., Questa H., et al. Percutaneous cecostomy for management of fecal incontinence in pediatric patients. J Vasc Interv Radiol 18 (2007) 982-985
100. Mousa H.M., van den Berg M.M., Caniano D.A., et al. Cecostomy in children with defecation disorders. Dig Dis Sci 51 (2006) 154-160